CENTENE CORPORATION HAS LONG FOCUSED ON DELIVERING BETTER
healthcare at lower costs. Centene is the largest Medicaid managed care organization in the U.S.,
a national leader in managed long-term services and supports, and the largest insurer on the Health
Insurance Marketplace. Ranked among Fortune’s Most Admired Companies, the St. Louis–based
organization maintains contracts in 32 states and an international presence.
By leveraging cutting-edge technology to better serve its members, Centene harnesses the
latest tools to help improve health outcomes. Developing complex algorithms through machine
learning to better predict human behavior means that the company can proactively deliver special-
ized programs and targeted interventions to
individuals most in need.
Centene leverages the power of Interpreta,
an analytics engine with a robust database that
can reveal which segments of the popula-
tion are more susceptible to important health
concerns. By analyzing 12 million medical data
points in less than a minute, Interpreta can
identify physiological changes that could signal
opportunities for additional care.
On the prescription drug side of member
care, Centene’s investment and partnership
with RxAdvance helps doctors identify potential
lower-cost options within therapeutic categories,
highlighting how prescribing decisions affect
treatment costs.
Centene has introduced the pharmacy
benefit manager’s (PBM) cloud-based platform,
beginning with its health plan in Mississippi,
Magnolia Health. All plans are expected to use
the platform by the end of 2020.
“We’ve made this important technology
investment to support a shift toward a more
transparent pharmacy benefit management
model, one that is sustainable with higher
quality and lower costs for consumers,” says
Michael Neidorff, chairman and chief executive
officer of Centene. “RxAdvance’s transparency,
disruptive technology, and unique approach to
partnership will help us further improve quality
health outcomes for our members and other
customers, while managing healthcare costs.”
By integrating pharmacy, medical, and lab
data, the customizable platform enables real-
time engagement by physicians, pharmacists,
and consumers. RxAdvance’s model fosters
compliance and reduces touch points in the pre-
scription process, automating aspects of claims
processing. It can also be used to optimize prescription drug spending.
Centene was ranked #1 on Fortune’s 100 Fastest-Growing Companies list based on revenue
growth over a 10-year period. This year, it expects to generate revenues exceeding $70 billion, and
Neidorff believes partnering with innovators like RxAdvance furthers Centene’s leadership position
in healthcare.
“Our continued investments in new technology have significantly enhanced our ability to scale,
coordinate, and deliver care,” says Neidorff. Still, “while we embrace technological progress, we
never lose sight of our purpose: Transforming the health of the community, one person at a time.”●CONTENT FROM CENTENE
Centene’s competitive advantage is driven bycapability, capacity, scale, investments in new technol-ogy, and more than 30 years of experience operatinggovernment-sponsored healthcare programs.Leveraging INNOVATIVETechnology to Reduce
The Cost of Healthcare